IL-10 Drives Glycolysis and Hinders Mitochondrial Pathways in Human Macrophages: Implications for Inflammatory Bowel Disease and Anti-TNF Treatment
Hung-Jen Chen(Amsterdam University Medical Centers), Menno P.J. de Winther(Amsterdam University Medical Centers), Daniel C. Sévin(GlaxoSmithKline (Germany)), Rab K. Prinjha(GlaxoSmithKline (United Kingdom)), Michel van Weeghel(Amsterdam University Medical Centers), H. Christian Eberl(GlaxoSmithKline (Germany)), Wouter J. de Jonge(University of Bonn), Beata S. Wyspianska(Age UK), Palwinder K. Mander(Age UK), Lee M. Booty(Walter and Eliza Hall Institute of Medical Research), Dyonne A.M. Lotgerink(Amsterdam University Medical Centers), Gerald Drewes(GlaxoSmithKline (Netherlands)), Cindy P. A. A. van Roomen(Amsterdam University Medical Centers), Guillermo R. Griffith(Amsterdam University Medical Centers), Paola Grandi(GlaxoSmithKline (Germany))
Cited by 1
Related Papers
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
|Nature|2011|1.5k
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
|Nature Immunology|2005|1.1k
Quantitative Interaction Proteomics and Genome-wide Profiling of Epigenetic Histone Marks and Their Readers
|Cell|2010|815
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
|Nature Biotechnology|2011|666
The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation
|British Journal of Pharmacology|2007|634